ALEXANDRIA, Va., May 5 -- United States Patent no. 12,618,839, issued on May 5, was assigned to Arizona Board of Regents on Behalf of Arizona State University (Scottsdale, Ariz.).

"Antibodies for detecting Epstein Barr virus-positive gastric cancer" was invented by Joshua LaBaer (Chandler, Ariz.), Lusheng Song (Tempe, Ariz.), Ji Qiu (Chandler, Ariz.) and Yunro Chung (Chandler, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods, compositions, kits, and systems for detecting Epstein Barr virus infection (EBV) in gastric cancer (GC) patients. In particular, provided herein are methods, composition, kits, and systems for diagnosing and treating EBV-positive gastric cancer (EBV+ GC) ...